|Day Low/High||2.90 / 2.99|
|52 Wk Low/High||1.41 / 3.67|
Intellipharmaceutics (IPCI) and Mallinckrodt (MNK) have reached a license and commercial supply agreement.
The promotion of Paul Campanelli to CEO indicates a change in the company's focus from acquiring other firms to its roots as a generic pharmaceutical firm.
Catalent and West Pharmaceutical Services provide products and services to biotech and pharmaceutical firms. Intellipharmaceutics is a small-cap firm on the rise.
These under-$10 stocks are making big moves higher. Here's how to trade them from here.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.